According to IMARC Group’s latest report, titled “Tissue Engineering Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.’ the study provides a detailed analysis of the industry, including the global tissue engineering market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the tissue engineering market?
The global tissue engineering market size reached US$ 15.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.5 Billion by 2028, exhibiting a growth rate (CAGR) of 12.91% during 2023-2028.
What are Tissue Engineering?
Tissue engineering is a multidisciplinary field that combines biology, engineering, and medicine to create functional tissue substitutes for damaged or diseased organs and tissues. It involves the development and implementation of techniques to stimulate the regeneration, repair, or replacement of damaged or lost tissues using biomaterials, growth factors, and cells. Tissue engineering aims to address the limitations of traditional transplantation methods by creating custom-made tissue constructs that can restore or enhance the function of damaged organs or tissues. This innovative approach holds tremendous potential for the treatment of various medical conditions, including organ failure, skin injuries, cardiovascular diseases, and orthopedic disorders. By harnessing the principles of cell biology and engineering, tissue engineering offers promising solutions for improving patient outcomes and quality of life.
Request for a PDF sample of this report: https://www.imarcgroup.com/tissue-engineering-market/requestsample
What are the growth prospects and trends in the tissue engineering industry?
The increasing prevalence of chronic diseases and age-related conditions represents one of the key factors driving the growth of the global tissue engineering market. In line with this, the rising demand for tissue engineering solutions, along with the growing aging population and rising instances of chronic illnesses, such as cardiovascular diseases, diabetes, and osteoarthritis, are contributing to the growth of the market. Tissue engineering techniques provide opportunities for regenerative therapies, enabling the repair and restoration of damaged tissues, and offering potential alternatives to conventional treatments which are boosting the growth of the market. The market is also driven by advancements in biotechnology and biomaterials. Innovations in biomaterials, such as scaffolds, hydrogels, and 3D printing technologies, are significantly enhancing the development and implementation of tissue engineering strategies. These advancements enable the creation of biocompatible and functional tissue constructs that closely mimic the properties of natural tissues, promoting cellular integration and tissue regeneration which is fueling the growth of the market. Other factors, such as the increasing focus on personalized medicine and patient-specific treatments, and rising collaborations and partnerships between academic institutions, research organizations, and biotechnology companies, are creating a positive outlook for the market across the globe.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Type:
- Synthetic Scaffold Material
- Biologically Derived Scaffold Material
- Others
Breakup by Application:
- Orthopedics and Musculoskeletal
- Neurology
- Cardiovascular
- Skin and Integumentary
- Dental
- Others
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Facilities
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Who are the key players operating in the industry?
The report covers the major market players including:
- AbbVie Inc.
- Braun Melsungen AG
- Baxter International Inc
- Becton
- Dickinson and Company
- Integra LifeSciences Corporation
- Organogenesis Holdings Inc
- RTI Surgical
- Smith Nephew plc
- Stryker Corporation
- Vericel Corporation
- Zimmer Biomet.
Ask Analyst for Customization and Explore full report with TOC List of Figures: https://www.imarcgroup.com/request?type=reportid=4880flag=F
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
